Inotiv, Inc. (NOTVQ) - Total Assets
Based on the latest financial reports, Inotiv, Inc. (NOTVQ) holds total assets worth $702.42 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Inotiv, Inc. short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Inotiv, Inc. - Total Assets Trend (1997–2025)
This chart illustrates how Inotiv, Inc.'s total assets have evolved over time, based on quarterly financial data.
Inotiv, Inc. - Asset Composition Analysis
Current Asset Composition (September 2025)
Inotiv, Inc.'s total assets of $702.42 Million consist of 25.2% current assets and 74.8% non-current assets. Also see Inotiv, Inc. (NOTVQ) market capitalisation for the company's overall valuation and market capitalisation.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.8% |
| Accounts Receivable | $97.45 Million | 12.6% |
| Inventory | $45.74 Million | 5.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $240.20 Million | 31.2% |
| Goodwill | $94.29 Million | 12.2% |
Asset Composition Trend (1997–2025)
This chart illustrates how Inotiv, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Inotiv, Inc. stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Inotiv, Inc.'s current assets represent 25.2% of total assets in 2025, a decrease from 33.3% in 1997.
- Cash Position: Cash and equivalents constituted 2.8% of total assets in 2025, up from 1.3% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 43.0% of total assets, an increase from 1.0% in 1997.
- Asset Diversification: The largest asset category is intangible assets at 31.2% of total assets.
Inotiv, Inc. Competitors by Total Assets
Key competitors of Inotiv, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB
|
India | Rs31.46 Billion |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Prodia Widyahusada Tbk PT
JK:PRDA
|
Indonesia | Rp2.57 Trillion |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Genetic Signatures Ltd
AU:GSS
|
Australia | AU$49.04 Million |
|
IZOTROPIC CORP.
F:1R3
|
Germany | €685.34K |
|
ALPHAHELIX MOL.DIAGN. SK1
F:4MB
|
Germany | €13.12 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
Inotiv, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.27 | 1.50 | 0.50 |
| Quick Ratio | 0.19 | 1.18 | 0.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-395.82 Million | $58.25 Million | $-18.20 Million |
Inotiv, Inc. - Advanced Valuation Insights
This section examines the relationship between Inotiv, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.01 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -1.3% |
| Total Assets | $771.11 Million |
| Market Capitalization | $390.42K USD |
Valuation Analysis
Below Book Valuation: The market values Inotiv, Inc.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Inotiv, Inc.'s assets decreased by 1.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Inotiv, Inc. (1997–2025)
The table below shows the annual total assets of Inotiv, Inc. from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $771.11 Million | -1.31% |
| 2024-09-30 | $781.36 Million | -8.78% |
| 2023-09-30 | $856.53 Million | -11.05% |
| 2022-09-30 | $962.90 Million | +199.17% |
| 2021-09-30 | $321.86 Million | +422.55% |
| 2020-09-30 | $61.59 Million | +46.72% |
| 2019-09-30 | $41.98 Million | +34.26% |
| 2018-09-30 | $31.27 Million | +53.15% |
| 2017-09-30 | $20.42 Million | -3.42% |
| 2016-09-30 | $21.14 Million | -11.24% |
| 2015-09-30 | $23.82 Million | +0.17% |
| 2014-09-30 | $23.77 Million | -7.12% |
| 2013-09-30 | $25.60 Million | -5.11% |
| 2012-09-30 | $26.98 Million | -16.60% |
| 2011-09-30 | $32.35 Million | +8.75% |
| 2010-09-30 | $29.74 Million | -8.72% |
| 2009-09-30 | $32.59 Million | -19.24% |
| 2008-09-30 | $40.35 Million | -4.02% |
| 2007-09-30 | $42.04 Million | -0.65% |
| 2006-09-30 | $42.31 Million | -11.55% |
| 2005-09-30 | $47.84 Million | +2.23% |
| 2004-09-30 | $46.80 Million | +4.02% |
| 2003-09-30 | $44.99 Million | +34.43% |
| 2002-09-30 | $33.46 Million | +19.61% |
| 2001-09-30 | $27.98 Million | +4.93% |
| 2000-09-30 | $26.66 Million | +1.38% |
| 1999-09-30 | $26.30 Million | +17.94% |
| 1998-09-30 | $22.30 Million | +40.25% |
| 1997-09-30 | $15.90 Million | -- |
About Inotiv, Inc.
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences researc… Read more